Top Low Price Companies To Own In Right Now

When Google (NASDAQ: GOOG  ) announced its new Chromecast device yesterday, tech sites exploded with initial reviews. Wired even called it "Google's Miracle Device." I wouldn't go that far just yet, but there are two reasons why the small stick could disrupt its streaming competitors.

Priced to sell
The first and probably the most obvious selling point for the Chromecast is its ridiculously low price: $35. That's significantly lower than Apple TV and even $15 less than Roku's cheapest streaming box. Google chose the perfect price point for launching such a device, considering its Google TV has never taken off and Apple TVs and Rokus already dominate the market.

Source: Google.

If Google had come in the $50 to $100 range, the device would've had to come with much more features, and couldn't be just the basic Wi-Fi device-pairing system that it is. As it stands, Chromecast is a simple way to stream music, movies, and video a from a user's PC, Android, or iOS device.

Top Low Price Companies To Own In Right Now: Gevo Inc (GEVO)

Gevo, Inc., incorporated in June 2005, is a renewable chemicals and advanced biofuels company. The Company is focused on the development and commercialization of alternatives to petroleum-based products. The Company operates in two segments: Gevo, Inc. Segment and Gevo Development/Agri-Energy Segment. Gevo, Inc. Segment is responsible for all research and development activities related to the future production of isobutanol, maintaining and protecting its intellectual property portfolio, developing future markets for its isobutanol and providing corporate oversight services. Its Gevo Development/Agri-Energy Segment is responsible for the production of ethanol and related products. In September 2010, the Company acquired a 22 MGPY ethanol production facility in Luverne, Minnesota that the Company intends to retrofit to produce isobutanol.

The Company�� isobutanol can also be converted by its customers into a range of hydrocarbons, which form the basis for the production of many products, including plastics, fibers, rubber and other polymers and hydrocarbon fuels, including jet and diesel fuel. Its technology platform consists of biocatalysts and a isobutanol separation unit. Together these technologies form the Gevo Integrated Fermentation Technology (GIFT). GIFT is designed to allow relatively low capital expenditure retrofits of existing ethanol facilities, enabling isobutanol production from a range of renewable feedstocks. The Company�� biocatalysts are microorganisms that have been designed to metabolize sugars to produce isobutanol.

GIFT consists of two components, biocatalysts which convert sugars derived from multiple renewable feedstocks into isobutanol through fermentation, and a separation unit which is designed to continuously separate isobutanol from water during the fermentation process. The Company developed its technology platform to be compatible with the existing approximately 20 BGPY of global operating ethanol production capacity, as estimated by the R! enewable Fuels Association (RFA).

The Company competes with Butamax Advanced Biofuels LLC (Butamax), BP p.l.c. (BP), E. I. du Pont de Nemours and Company, Butalco GmbH, Cathay Industrial Biotech Ltd., METabolic EXplorer S.A., TetraVitae Bioscience, Inc., Cobalt Technologies, Inc., Green Biologics Ltd. Shell Oil Products US (Shell Oil), BP, DuPont-Danisco Cellulosic Ethanol LLC, Abengoa Bioenergy, S.A., POET, LLC, ICM, Mascoma, Range Fuels, Inbicon A/S, INEOS New Planet BioEnergy LLC, Coskata, Archer Daniels Midland Company, BlueFire Ethanol, Inc., KL Energy Corporation, ZeaChem Inc., Iogen Corporation, Qteros, Inc., and AE Biofuels, Inc.

Advisors' Opinion:

• [By Robert Rapier]

  KiOR (Nasdaq: KIOR) is one of three advanced biofuel companies that venture capitalist Vinod Khosla took public in 2011. The other two were Amyris (Nasdaq: AMRS) and Gevo (Nasdaq: GEVO). Each of these companies has seen its share price drop sharply since the IPO. While KiOR is one of the few companies to have produced advanced biofuel for sale, the volumes have consistently come in below company guidance, and I expect production costs to remain above the sales price for the foreseeable future.

• [By Maxx Chatsko]

  The real news came this morning, when�Gevo (NASDAQ: GEVO  ) �announced that it had resumed commercial production of isobutanol at its Luverne biorefinery. The company had outlined its plans in prior conference calls, and its guidance earlier this year. But, given contamination obstacles at Luverne last summer, I suppose investors have reserved the right to remain cautious. Now that commercial production of isobutanol is finally happening, what exactly does this mean for investors?

Top Low Price Companies To Own In Right Now: MEMSIC Inc.(MEMS)

MEMSIC, Inc. provides semiconductor sensor and system solutions based on integrated micro electro-mechanical systems (MEMS) technology and mixed signal circuit design. It offers sensor products, principally accelerometers. The company?s sensors are used for motion, direction, and pressure sensing applications; and accelerometer products are used to measure tilt, shock, vibration, and acceleration, as well as in various applications, such as mobile phones, automotive safety systems, video projectors, global positioning systems, video gaming systems, interactive toys, inclination sensing, earthquake detection, cardiac pacemakers, and image projectors. Its system solution products include wireless sensors that connect the physical environment with enterprise management and information systems to provide monitoring, automation, and control solutions for a range of industries, as well as inertial systems that provide end-users and systems integrators with MEMS-based solutions for the measurement of static and dynamic motion in a various environments, such as avionics, remotely operated vehicles, agricultural and construction vehicles, automotive test, and wind power turbines. The company also engages in the development of multi-sensor and MCU integrated system products at the integrated circuit level for the consumer and mobile market, as well as at the module level for the industrial, automotive, and general aviation markets. It sells its products directly, as well as through systems integrators, resellers, distributors, and sales representatives worldwide. The company was founded in 1999 and is headquartered in Andover, Massachusetts.

Advisors' Opinion:

• [By Triska Hamid]

  In Abu Dhabi, researchers at the ATIC-SRC Center of Excellence for Energy Efficient Electronic Systems (ACE4S), a center jointly established by the Advanced Technology Investment Company and the Semiconductor Research Corporation, are working on the development of systems on chip (SOC) and micro-electromechanical systems (MEMs) in health care.

Top 10 Restaurant Stocks For 2015: Brookfield Property Partners LP (BPY)

Brookfield Property Partners L.P., incorporated on January 3, 2013, is a commercial real estate owner, operator and investor operating globally. The Company�� diversified portfolio includes interests in over 300 office and retail properties encompassing approximately 250 million square feet. In addition, the Company has interests in approximately 19,800 multi-family units, 29 million square feet of industrial space and an 18 million square foot office development pipeline. The Company�� properties are located in North America, Europe, Australia and Brazil. The Company�� business is organized in four operating platforms, which include office, retail, multi-family & industrial and opportunistic investments.

Office

Through a series of public and private vehicles, Brookfield Property Partners is engaged in the ownership and management of office portfolios, owning, developing and managing premier office properties in the United States, Canada, Australia and the United Kingdom. Brookfield Office Properties (BPO), is the Company�� global pure-play office company, and consists of its office portfolio and operational platform. Brookfield Property Partners owns 50% of BPO. Brookfield Property Partners' office portfolio is consists of interests in 124 office properties totaling over 80 million square feet of commercial space. These properties are primarily located in the downtown centers of New York, Washington, D.C., Houston, Los Angeles, Toronto, Calgary, Ottawa, Sydney, Melbourne and Perth.

Retail

The Company owns and manages interests in approximately 170 retail assets, predominantly in the United States and Brazil. These properties encompass approximately 156 million square feet of retail space, primarily concentrated in the United States based malls of General Growth Properties, Inc (GGP).

Multi-family

Through Brookfield's private opportunistic funds Brookfield Property Partners controls approximately 15,600 multifamil! y units throughout North America. Fairfield Residential (Fairfield) forms the basis of its multi-family platform.

Industrial

Through Brookfield's private opportunistic funds Brookfield Property Partners controls 29 million square feet of industrial space, including approximately 81% of the common equity in Verde, an owner, operator and developer of industrial distribution facilities in the United States and Mexico. Verde owns 110 industrial distribution facilities consists of 18 million square feet of space in the United States distribution markets and gateway trade markets along the United States and Mexican border, as well as over 20,000 acres of land intended for future sale and development.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Shares of Brookfield Office Properties (NYSE: BPO) got a boost, shooting up 13.45 percent to $19.02 after Brookfield Property Partners (NYSE: BPY) proposed to acquire Brookfield Office Properties for $19.34 per share.

• [By Luke Jacobi]

  Brookfield Office Properties (NYSE: BPO) got a boost, closing up 13.71 percent to $19.07 after Brookfield Property Partners (NYSE: BPY) proposed to acquire Brookfield Office Properties for $19.34 per share.

Top Low Price Companies To Own In Right Now: ACADIA Pharmaceuticals Inc.(ACAD)

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on drug discovery and clinical development of novel treatments for central nervous system disorders. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase III clinical development as a treatment for Parkinson's disease psychosis. It is also developing AGN-XX/YY, a product candidate in Phase II for chronic pain; and AC-262271, a product candidate in Phase I for glaucoma in collaboration with Allergan, as well as AM-831, a product candidate in IND-track development in collaboration with Meiji Seika Kaisha, Ltd. In addition, ACADIA Pharmaceuticals Inc. is developing two preclinical programs in the area of Parkinson?s disease. The product candidates in the company?s pipeline emanate from discoveries made using its proprietary drug discovery platform. The company was founded in 1993 and is headquartered in San Diego, California.

Advisors' Opinion:

• [By David Williamson]

  After an incredible performance in late March, when shares of Acadia Pharmaceuticals (NASDAQ: ACAD  ) jumped up 23%, they have once again exploded today, up 40% intraday. What's behind these massive leaps for this pharmaceutical company, and is there more on the way? In this video, Motley Fool health-care analyst David Williamson tells investors about the drug that has Acadia investors so excited, why it has so many competitive advantages, and what investors need to watch from here.

• [By Rick Munarriz]

  Tuesday
  ACADIA Pharmaceuticals (NASDAQ: ACAD  ) checks in on Tuesday. The biotech company's lead candidate is pimavanserin, a promising drug that's in the third and final phase of clinical development as a treatment for Parkinson's disease psychosis. Naturally, investors see red ink here, but analysts do see the quarterly deficit narrowing this time around.

• [By Keith Speights]

  One and done
  No more tests required. That's the word from the Food and Drug Administration to Acadia Pharmaceuticals (NASDAQ: ACAD  ) this week. Acadia's shares skyrocketed more than 60% on the news.

• [By Bio-Wire]

  Baker Bros. Advisors is a ~5 BB small & micro-cap focused biotechnology fund run by Julian Baker and Felix Baker. The fund has generated exceptional returns this year ��largely due to a huge long position they started in ACADIA Pharmaceuticals (NASDAQ: ACAD) (YTD = +481%). While the fund is quite secretive, it is required file SEC Form 13F which allows the public to see which particular biotech stocks are being accumulated.

Top Low Price Companies To Own In Right Now: Armstrong World Industries Inc (AWI)

Armstrong World Industries, Inc. (AWI), incorporated on December 30, 1891, is a global producer of flooring products and ceiling systems for use in the construction and renovation of residential, commercial and institutional buildings. The Company designs, manufactures and sells flooring products (resilient and wood) and ceiling systems (mineral fiber, fiberglass and metal) globally. The Company segments includes: Building Products, Resilient Flooring and Wood Flooring. The Company�� Building Products, Resilient Flooring, Wood Flooring and Cabinets segments sell products for use in the home. Its products are used in new home construction and existing home renovation work. Its products, primarily ceilings and Resilient Flooring, are used in commercial and institutional buildings. On September 1, 2012, it sold Patriot Flooring Supply, Inc. to The Belknap White Group. Effective October 31, 2012, the Company sold of its cabinets business to American Industrial Partners.

Building Products

Building Products produces suspended mineral fiber, soft fiber and metal ceiling systems for use in commercial, institutional and residential settings. In addition, its Building Products segment sources complementary ceiling products. Its products, which are sold globally, are available in colors, performance characteristics and designs, and offer attributes, such as acoustical control, rated fire protection and aesthetic appeal. Commercial ceiling materials and accessories are sold to ceiling systems contractors and to resale distributors. Residential ceiling products are sold in North America to wholesalers and retailers, including home centers. Suspension system (grid) products manufactured by Worthington Armstrong Venture (WAVE) are sold by both the Company and WAVE.

Resilient Flooring

Resilient Flooring produces and sources a range of floor coverings for homes and commercial and institutional buildings. Manufactured products in this segment include vinyl sheet, v! inyl tile and linoleum flooring. In addition, its Resilient Flooring segment sources and sells laminate flooring products, vinyl tile products, vinyl sheet products, adhesives, and installation and maintenance materials and accessories. Resilient Flooring products are offered in a range of types, designs, and colors. It sells these products globally to wholesalers, home centers, retailers, contractors and to the manufactured homes industry.

Wood Flooring

The Company�� Wood Flooring segment produces and sources wood flooring products for use in new residential construction and renovation, with commercial applications in stores, restaurants and offices. The product offering includes pre-finished solid and engineered wood floors in various wood species, and related accessories. All of its Wood Flooring sales are in North America. Its Wood Flooring products are sold to independent wholesale flooring distributors and home centers.

The Company competes with Saint-Gobain, Chicago Metallic Corporation, Georgia-Pacific Corporation, Knauf AMF GmbH & Co. KG, Lafarge SA, Odenwald Faserplattenwerk GmbH, Rockfon A/S, USG Corporation, Amtico International, Inc., Beaulieu International Group, N.V., Boa-Franc, Inc., Congoleum Corporation, Faus, Inc., Forbo Holding AG, Gerflor Group, Interface, Inc., IVC Group, Krono Holding AG, LG Floors, Mannington Mills, Inc., Metroflor Corporation, Mullican Flooring, L.P., Mohawk Industries, Inc., Nora Systems GmbH, Pfleiderer AG, Shaw Industries, Inc., Somerset Hardwood Flooring, Tarkett AG.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Armstrong World Industries (NYSE: AWI  ) , whose recent revenue and earnings are plotted below.

Top Low Price Companies To Own In Right Now: Dno International ASA (DTNOF.PK)

DNO International ASA is a Norway-based oil and gas exploration and production company. It is engaged in the acquisition, development and operation of oil and gas properties. Its activities are primarily undertaken in the Middle East and the North African (MENA) region. It holds stakes in oil and gas blocks in various stages of exploration, development and production both onshore and offshore in the Kurdistan region of Iraq, the Republic of Yemen, the Sultanate of Oman, the United Arab Emirates, the Tunisian Republic and Somaliland. The Company operates through its head office in Oslo, and a network of offices throughout the MENA region. Its subsidiaries include DNO Yemen AS, DNO UK Ltd, DNO Invest AS, DNO Tunisia AS, DNO Iraq AS and DNO Mena AS. In January 2014, it completed the the farm-in by its subsidiary DNO Tunisia AS to the Sfax Offshore Exploration Permit and the Ras El Besh Concession in Tunisia, in which DNO Tunisia AS now holds 87.5% participating (100% paying) interest. Advisors' Opinion:

• [By Street Smart Investor]

  DNO International (DTNOF.PK), an independent exploration and production company, has surged by 43% in 2013. The upside trend is not over for the stock with potential triggers for further upside over the next one year. This research presents the reasons for the bullish outlook and the stock's upside potential considering the best case and worst case scenario for the company. The scenario analysis concludes on a 25-42% upside in the given time horizon.

Top Low Price Companies To Own In Right Now: Takeda Pharmaceutical Co Ltd (TKPHF.PK)

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Company operates in three business segments. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications, vitamin drops and vaccines, among others. The Healthcare segment manufactures and sells general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products. Advisors' Opinion:

• [By Alpha Exposure]

  The most recent Affymax article states that Takeda withdrew from consideration for European approval "because they were doing the "root cause analysis" they would not be able to complete the investigation because it was still in process and "ongoing" despite the fact that severe reactions were not present at the time of the clinical trials." However, there is no evidence to support this conclusion. The truth is that we showed you an excerpt directly from the Committee for Medicinal Products for Human Use that stated the CHMP "was of the provisional opinion that Omontys could not have been approved" due to "study results indicating that Omontys may increase the risk of death or heart and circulatory problems." It is clear that the EU application was withdrawn because Takeda (TKPHF.PK) could not get Omontys approved due to its safety profile.

• [By Markus Aarnio]

  Companies working on chemically synthesized siRNAs include Merck (MRK), through its subsidiary Sirna Therapeutics, Inc., Novartis (NVS), Takeda (TKPHF.PK), Kyowa Hakko Kirin, Marina Biotech, Inc., Arrowhead and its subsidiary, Calando, Quark, Silence Therapeutics plc, Tekmira (TKMR), Sylentis and Dicerna Pharmaceuticals, Inc.